• No results found

Chronic liver disease (CLD)

Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol

Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol

... Chronic liver disease (CLD) is a major health burden worldwide, with 29 million people in Europe affected by this condition ...[1]. Liver cirrhosis, also known as end- stage CLD, ...

8

Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease

Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease

... CH-C: Chronic hepatitis C; CLD-C: HCV-related chronic liver disease; DM: Diabetes mellitus; HCV: Hepatitis C virus; HOMA-IR: Homeostasis model for assessment of insulin resistance; ...

10

Health-related quality of life and survival in Chinese patients with chronic liver disease

Health-related quality of life and survival in Chinese patients with chronic liver disease

... Chronic liver disease (CLD) is known to cause significant morbidity and mortality, typically due to a number of complications that include ascites, hepatic encephalop- athy, variceal ...

8

Unexplained chronic liver disease in Ethiopia: a cross-sectional study

Unexplained chronic liver disease in Ethiopia: a cross-sectional study

... of chronic liver disease (CLD) in sub-Saharan ...of CLD is less well documented and hence opportunities to modulate other potential risk factors are being ...of CLD in eastern ...

12

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis

... with chronic liver disease who visited Hiroshima University Hospital from 2016 to 2017 were retrospectively investigated for itch frequency and ...with chronic liver disease at ...

8

Descriptive epidemiology of chronic liver disease in northeastern Italy: an analysis of multiple causes of death

Descriptive epidemiology of chronic liver disease in northeastern Italy: an analysis of multiple causes of death

... of CLD-related deaths by gender, age class, and geographical area; however, the selection of codes could be opportunely modulated based on the characteristics of the database at ...of CLD were not included, ...

7

Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease

Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease

... in CLD. However, the odds ratio for both cirrhosis and chronic hepatitis was higher than that for age, implying a stronger association of the former fac- ...diovascular disease is rare in cirrhosis ...

7

Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol)

Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol)

... or chronic (debili- tating and of greater than 6 months duration ...in chronic illness. Among patients with CLD, even though fatigue is the most prevalent symptom, its patho- genesis is not well ...

6

Factors influencing on health-related quality of life in South Korean with chronic liver disease

Factors influencing on health-related quality of life in South Korean with chronic liver disease

... Korea, CLD is a major disease with high prevalence along with hypertension and ...[1], CLD accounted for ...fatty liver, and inflammatory reaction and healing process that are repeated for a ...

8

TGF-β1 and TGF-β2 abundance in liver diseases of mice and men

TGF-β1 and TGF-β2 abundance in liver diseases of mice and men

... monolayer, CLD - chronic liver disease, Col1a1 – Collagen 1a1, CS - collagen sandwich, ELISA – enzyme–linked immunosorbent assay, HCC - hepatocellular carcinoma, HSC - hepatic stellate cell, ...

20

Weak Association between SEN Virus Viremia and Liver Disease

Weak Association between SEN Virus Viremia and Liver Disease

... non-C chronic liver disease (CLD) without HCC who were admitted to our hospital between 1995 and ...without liver disease served as controls and were also examined for ...with ...

6

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer

Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer

... for chronic liver disease (CLD) ...and liver cancer among subjects with chronic hepatitis B found that higher pre-diagnostic serum ret- inol was strongly associated with a ...

12

Spectrum of Precipitating Factors of Hepatic Encephalopathy in Cirrhosis of Liver

Spectrum of Precipitating Factors of Hepatic Encephalopathy in Cirrhosis of Liver

... Chronic liver disease and cirrhosis results in 26000-35000 deaths each year in ...the disease in the fifth or sixth decade of the ...Wilson’s disease and a variety of less common ...by ...

85

Serotype specific mortality from invasive Streptococcus pneumoniaedisease revisited

Serotype specific mortality from invasive Streptococcus pneumoniaedisease revisited

... renal disease, chronic liver disease, diabetes mel- litus, cancer, autoimmune disease, human immunodefi- ciency virus (HIV) infection, and 'other chronic ...

7

Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)

Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)

... Patient reported outcomes (PROs) such as HRQOL are surrogates for a patient’s experience [11]. Asses- sing PROs are important to accurately estimate the burden of chronic liver disease and its ...

7

Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia

Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia

... Abstract: A 50-year-old woman from Pulaski, Virginia, presented to a local clinic with headaches, fever, generalized joint pain, excessive thirst and fluid intake, and a progressing rash on her back. On physical ...

7

Severe but not mild hypercapnia affects the outcome in patients with severe cardiogenic pulmonary edema treated by non-invasive ventilation

Severe but not mild hypercapnia affects the outcome in patients with severe cardiogenic pulmonary edema treated by non-invasive ventilation

... or chronic heart failure, clinical signs of left and/or right cardiac failure, increase in NT-proBNP above 1000 pg/ml, bilateral alveolar and/or interstitial opacities on chest X-ray, and increase in left ...

8

Original Article Exploration and verification of liver fibrosis non-invasive diagnostic model in patients with chronic hepatitis B

Original Article Exploration and verification of liver fibrosis non-invasive diagnostic model in patients with chronic hepatitis B

... In the modeling group, cases were divided into 2 groups according to the degree of liver fibro- sis (F0-F1 subgroup and F2-F4 subgroup). Performed forward regression analysis was performed to evaluate the ...

8

The socioeconomic burden of chronic lung disease in low-resource settings across the globe – an observational FRESH AIR study

The socioeconomic burden of chronic lung disease in low-resource settings across the globe – an observational FRESH AIR study

... The patterns of absenteeism and presenteeism we have identified are similar in high-resource settings [23]. How- ever, in our study, absolute WPAI-scores were consider- ably higher for all outcomes but absenteeism. ...

10

Validation of CLIF C ACLF score to define a threshold for futility of intensive care support for patients with acute on chronic liver failure

Validation of CLIF C ACLF score to define a threshold for futility of intensive care support for patients with acute on chronic liver failure

... platelet count, albumin level, and WBC count were not different between survivors and nonsurvivors. Of the patients who survived, 26 (25%) were treated with renal replacement therapy, whereas 41 (41%) (p = 0.02) of the ...

8

Show all 10000 documents...

Related subjects